Reaction Details Report a problem with these data
Target
Serine/threonine-protein kinase pim-2
Ligand
BDBM50505050
Substrate
n/a
Meas. Tech.
ChEMBL_1817340 (CHEMBL4317000)
Ki
0.050000±n/a nM
Citation
Wang, X; Blackaby, W; Allen, V; Chan, GKY; Chang, JH; Chiang, PC; Dične, C; Drummond, J; Do, S; Fan, E; Harstad, EB; Hodges, A; Hu, H; Jia, W; Kofie, W; Kolesnikov, A; Lyssikatos, JP; Ly, J; Matteucci, M; Moffat, JG; Munugalavadla, V; Murray, J; Nash, D; Noland, CL; Del Rosario, G; Ross, L; Rouse, C; Sharpe, A; Slaga, D; Sun, M; Tsui, V; Wallweber, H; Yu, SF; Ebens, AJ Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma. J Med Chem 62:2140-2153 (2019) [PubMed] Article
More Info.:
Target
Name:
Serine/threonine-protein kinase pim-2
Synonyms:
PIM2 | PIM2_HUMAN | Pim-2h | Serine/threonine-protein kinase (PIM2) | Serine/threonine-protein kinase PIM | Serine/threonine-protein kinase pim-2 (PIM2)
Type:
Serine/threonine-protein kinase
Mol. Mass.:
34185.93
Organism:
Human
Description:
Q9P1W9
Residue:
311
Sequence:
MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP